These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 195006)

  • 41. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and physiological properties of temperature-sensitive mutants of Cocal virus.
    Pringle CR; Wunner WH
    J Virol; 1973 Oct; 12(4):677-83. PubMed ID: 4359947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nongenetic complementation in VSV: asymmetric contribution of the L proteins of each parent in the rescue of group I ts mutants.
    Deutsch V; Brun G
    Virology; 1983 Jan; 124(2):366-79. PubMed ID: 6297161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus.
    Reichmann ME; Pringle CR; Follett EA
    J Virol; 1971 Aug; 8(2):154-60. PubMed ID: 4107244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step.
    Miller DK; Lenard J
    J Cell Biol; 1980 Feb; 84(2):430-7. PubMed ID: 6247355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo assembly and maturation of vesicular stomatitis virus.
    Dal Canto MC; Rabinowitz SG; Johnson TC
    Lab Invest; 1976 Dec; 35(6):515-24. PubMed ID: 186663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.
    Johnson JE; Nasar F; Coleman JW; Price RE; Javadian A; Draper K; Lee M; Reilly PA; Clarke DK; Hendry RM; Udem SA
    Virology; 2007 Mar; 360(1):36-49. PubMed ID: 17098273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes.
    Lyles DS; McKenzie MO; Kaptur PE; Grant KW; Jerome WG
    Virology; 1996 Mar; 217(1):76-87. PubMed ID: 8599238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis.
    Francoeur AM; Poliquin L; Stanners CP
    Virology; 1987 Sep; 160(1):236-45. PubMed ID: 2820131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytopathic effects in mouse neuroblastoma cells during a non-permissive infection with a mutant of vesicular stomatitis virus.
    Dille BJ; Hughes JV; Johnson TC; Rabinowitz SG; Dal Canto MC
    J Gen Virol; 1981 Aug; 55(Pt 2):343-54. PubMed ID: 6270268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in peptide structure of vesicular stomatitis virus mutant and its central nervous system isolate.
    Hughes JV; Johnson TC
    J Gen Virol; 1981 Apr; 53(Pt 2):309-19. PubMed ID: 6267180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of the transcription and the replication of vesicular stomatitis virus by using temperature-sensitive mutants.
    Printz-Ané C; Combard A; Martinet C
    J Virol; 1972 Nov; 10(5):889-95. PubMed ID: 4344255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection of the central nervous system produced by R1 vesicular stomatitis virus.
    Greenstein JI; Baron-Van Evercooren AG; Lazzarini RA; McFarland HF
    Lab Invest; 1981 Jun; 44(6):487-95. PubMed ID: 6262567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus.
    Simon KO; Whitaker-Dowling PA; Youngner JS; Widnell CC
    Virology; 1990 Jul; 177(1):289-97. PubMed ID: 2162105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.
    Ahmed M; Marino TR; Puckett S; Kock ND; Lyles DS
    J Virol; 2008 Sep; 82(18):9273-7. PubMed ID: 18614644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus.
    Moller JR; Rager-Zisman B; Quan PC; Schattner A; Panush D; Rose JK; Bloom BR
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2456-9. PubMed ID: 2986117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of M protein aggregation in defective assembly of temperature-sensitive M protein mutants of vesicular stomatitis virus.
    Flood EA; McKenzie MO; Lyles DS
    Virology; 2000 Dec; 278(2):520-33. PubMed ID: 11118374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nongenetic complementation of group V temperature-sensitive mutants of vesicular stomatitis virus by UV-irradiated virus.
    Deutsch V
    J Virol; 1975 Apr; 15(4):798-805. PubMed ID: 163919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.